Concord Biotech: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 and further to our intimation dated November 06 2024 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for Second Quarter and half year ended September 30 2024 we wish to inform that the said Earning Call was held today at 02:00 PM (IST).